EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India



Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India



Journal of Gastroenterology and Hepatology 22(7): 1104-1111



Aim: To assess the role of hepatitis B virus (HBV), hepatitis C virus (HCV) and alcohol intake as risk factors for hepatocellular carcinoma (HCC) in the presence or absence of cirrhosis in Indian population.Methods: A total of 213 patients with HCC and 254 control subjects not affected with hepatic diseases or neoplasm were recruited. Odds ratios (ORs) were estimated for each risk factor and synergism among various risk factors was also studied.Results: The ORs and 95% confidence intervals (CI) of HCC were 48.02 (25.06-91.98) for any HBV marker, 38.98 (19.55-77.71) for HBsAg positivity, 12.34 (2.84-53.61) for HBsAg negative and antibody positive (either of anti-HBe or total anti-HBc), 5.45 (2.02-14.71) for anti-HCV positive and HCV RNA positive, and 2.83 (1.51-5.28) for heavy alcohol use. No significant risk increase was evident for subjects who were anti-HCV positive and HCV RNA negative. Synergism between alcohol and HCV infection in causing HCC was found, but not between alcohol and HBV. Overall, conclusive evidence of the presence or absence of cirrhosis was reached in 189 (88.73%) HCC patients; cirrhosis was present in 137 (72.48%) of them. ORs with 95% CI of HCC in the presence and absence of cirrhosis, respectively, for HBV were as follows: (i) 48.90 (24.61-97.19) and 35.03 (15.59-78.66) for any HBV marker; (ii) 39.88 (19.41-81.97) and 24.40 (10.60-56.18) for HBsAg positivity; and (iii) 12.10 (2.67-54.88) and 19.60 (3.94-97.39) for HBsAg negativity and antibody positivity. Significantly increased risk was found among cirrhotic patients for anti-HCV positivity and HCV RNA positivity [OR = 7.53 (2.73-20.78)] and for heavy alcohol use [OR = 3.32 (1.70-6.47)]; however, in the absence of cirrhosis, no significant risk increase was evident for subjects who were anti-HCV positive and HCV RNA positive [OR = 0.97 (0.11-8.54)], or who had history of heavy alcohol use [OR = 1.58 (0.55-4.53)].Conclusions: Infection with HBV and HCV are the major risk factors for the development of HCC in Indian patients. Presence of HBV antibodies even in the absence of HBsAg conferred increased risk for HCC in the presence or absence of cirrhosis. Anti-HCV positivity in the absence of HCV RNA conferred no increased risk. HCV RNA positivity and heavy alcohol use significantly increased the risk of HCC among cirrhotic patients, but not non-cirrhotic patients.

(PDF emailed within 0-6 h: $19.90)

Accession: 016950205

Download citation: RISBibTeXText

PMID: 17559381

DOI: 10.1111/j.1440-1746.2007.04908.x



Related references

Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study. Annals of Internal Medicine 116(2): 97-102, 1992

Prospective analysis of risk factors for hepatocellular carcinoma on patients with cirrhosis. Hepatology 38(4): 1061; Author Reply 1061-1061; Author Reply 1061, 2003

Clinicalpathological analysis of risk factors for the development of hepatocellular carcinoma after surgery for esophageal varices due to underlying cirrhosis or pre-cirrhosis in the 397 patients. Hepatology Research 25(1): 62-70, January, 2003

Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis. Hepatology 37(3): 520-527, 2003

Risk factors for hepatocellular carcinoma in patients with chronic liver disease: a case-control study. Cancer Causes & Control 23(3): 455-462, 2012

Risk factors in development of hepatocellular carcinoma in cirrhosis prospective study of 613 patients. Lancet 1(8442): 1357-1360, 1985

Risk factors for hepatocellular carcinoma in cirrhosis due to nonalcoholic fatty liver disease: A multicenter, case-control study. World Journal of Hepatology 9(7): 385-390, 2017

Hepatitis B and C virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma: A case-control study. Liver 14(2): 98-102, 1994

Smoking, obesity and alcohol are important risk factors in American patients with hepatocellular carcinoma A case control Study. Hepatology 38(4 Suppl 1): 278A-279A, October, 2003

Multivariate analysis of risk factors for hepatocellular carcinoma in patients with hepatitis C virus-related liver cirrhosis. Journal Of Gastroenterology. 31(4): 552-558, 1996

A multivariate analysis of risk factors for hepatocellular carcinoma in Japanese patients with liver cirrhosis associated hepatitis C virus. Gastroenterology 106(4 SUPPL ): A875, 1994

Anti-tuberculosis treatments and risk of hepatocellular carcinoma in tuberculosis patients with liver cirrhosis: a population-based case-control study. European Journal of Clinical Microbiology & Infectious Diseases 34(3): 479-485, 2015

Liver stiffness measurement in patients with cirrhosis and hepatocellular carcinoma: a case-control study. European Journal of Gastroenterology & Hepatology 21(2): 214-219, 2010

Risk factors for the recurrence of hepatocellular carcinoma after radiofrequency ablation of hepatocellular carcinoma in patients with hepatitis C. World Journal of Gastroenterology 11(14): 2174-2178, 2005

A long-term follow-up study on risk factors for hepatocellular carcinoma among Japanese patients with liver cirrhosis. Japanese Journal of Cancer Research 89(12): 1241-1250, 1998